| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |